Dear Editor, Recurrent Guillain-Barré syndrome (GBS) is a rare condition that reportedly appears in 2-5% of patients with GBS. 1 The clinical and pathophysiological characteristics of recurrent GBS have not been fully elucidated. Anti-ganglioside antibodies have been reported in a small number of cases of recurrent GBS. Herein we report on a case of recurrent GBS with anti-GT1a and anti-GQ1b ganglioside antibodies.
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the same anti-ganglioside antibodies during each attack. A few cases of recurrent GBS with anti-ganglioside antibodies have been reported, and are summarized in Table 1 . [3] [4] [5] Previous reports of recurrent GBS with anti-ganglioside antibodies have described shorter intervals between the attacks and more-severe neurological deterioration during recurrences. Recurrent GBS is typically reported to present with similar clinical manifestations during different attacks even when different conditions are present prior to the attacks. 3 However, some cases of recurrent GBS with different phenotypes during recurrent attacks have been reported. 4 These findings suggest that genetic or immunological factors are associated with the pathogenesis of recurrent GBS.
In conclusion, the clinical manifestations of recurrent GBS are heterogeneous, and the associated risk factors remain unclear. Genetic and immunological host factors and anti-ganglioside antibodies might affect the clinical manifestations and pathophysiology of recurrent GBS. Further studies are needed to obtain a deeper understanding of the clinical and pathophysiological factors underlying recurrent GBS.
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